Fluzoparib+Bevacizumab/Dietary Intervention vs Fluzoparib Monotherapy as First-line Maintenance in HRD+/- Advanced Ovarian Cancer
Clinical trial NCT06954584 · RECRUITING
Trial details
- NCT number
- NCT06954584
- Sponsor
- Tongji Hospital
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-27
- Primary completion
- 2030-05-01
- Enrollment
- 424
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.